JAMA Medical News

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Testosterone Use Rises Among Women, but Does the Evidence Support It?"

Related Content:
Testosterone Use Rises Among Women, but Does the Evidence Support It?

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What?"

Related Content:
Lp(a)-Reducing Agent Pelacarsen Misses the Mark in Phase 3—Now What?

JAMA Medical News Associate Managing Editor Kate Schweitzer and Lead Senior Staff Writer Rita Rubin discuss "Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain."

Related Content:
Unapproved GLP-1 Drugs Retatrutide and Zenagamtide Sold Online Are No Bargain

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss 1 in 5 Children Report Using AI for Emotional Support--Is It Good News or Bad?

Related Content:
More Than 1 in 5 Children Report Using AI for Emotional Support—Is It Good News or Bad?

JAMA Medical News Director Jennifer Abbasi and Associate Managing Editor Kate Schweitzer discuss "Remove the Fallopian Tubes If the Opportunity Arises, ACOG Says in New Ovarian Cancer Prevention Guidance."

Related Content:
Remove the Fallopian Tubes If the Opportunity Arises, ACOG Says in New Ovarian Cancer Prevention Guidance